Eledon Pharmaceuticals ELDN
NASDAQ ELDN
$2.29 +0.03 (+1.55%)
As of: Oct 21, 2026 · 11:41 AM EDT

Eledon Pharmaceuticals (ELDN) Total Debt (2016)

Updated

Eledon Pharmaceuticals' Total Debt came in at $3.45 million for Q4 2016.

Analysis

Eledon Pharmaceuticals (ELDN) Total Debt (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 49.04 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 70.82 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 32.35 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 26.25 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 63.19 Bn
10 Eledon Pharmaceuticals 257.38 Mn 168.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 3.45 Mn
API Access

Eledon Pharmaceuticals Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=ELDN&period=max&api_key=YOUR_API_KEY